FR2281766A1 - Oestratetraenes et medicament contenant ces substances - Google Patents

Oestratetraenes et medicament contenant ces substances

Info

Publication number
FR2281766A1
FR2281766A1 FR7524933A FR7524933A FR2281766A1 FR 2281766 A1 FR2281766 A1 FR 2281766A1 FR 7524933 A FR7524933 A FR 7524933A FR 7524933 A FR7524933 A FR 7524933A FR 2281766 A1 FR2281766 A1 FR 2281766A1
Authority
FR
France
Prior art keywords
oestratetraenes
substances
products containing
medicinal products
medicinal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7524933A
Other languages
English (en)
French (fr)
Other versions
FR2281766B1 (US08088918-20120103-C00476.png
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of FR2281766A1 publication Critical patent/FR2281766A1/fr
Application granted granted Critical
Publication of FR2281766B1 publication Critical patent/FR2281766B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0062—Estrane derivatives substituted in position 17 alfa not substituted in position 17 beta
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7524933A 1974-08-12 1975-08-11 Oestratetraenes et medicament contenant ces substances Granted FR2281766A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2439082A DE2439082A1 (de) 1974-08-12 1974-08-12 17 alpha-hydroxy-1,3,5(10),15-oestratetraene und verfahren zu ihrer herstellung

Publications (2)

Publication Number Publication Date
FR2281766A1 true FR2281766A1 (fr) 1976-03-12
FR2281766B1 FR2281766B1 (US08088918-20120103-C00476.png) 1980-04-11

Family

ID=5923222

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7524933A Granted FR2281766A1 (fr) 1974-08-12 1975-08-11 Oestratetraenes et medicament contenant ces substances

Country Status (9)

Country Link
US (1) US4016269A (US08088918-20120103-C00476.png)
JP (1) JPS5148646A (US08088918-20120103-C00476.png)
BE (1) BE832364A (US08088918-20120103-C00476.png)
CH (1) CH624684A5 (US08088918-20120103-C00476.png)
DE (1) DE2439082A1 (US08088918-20120103-C00476.png)
DK (1) DK135997C (US08088918-20120103-C00476.png)
FR (1) FR2281766A1 (US08088918-20120103-C00476.png)
GB (1) GB1515864A (US08088918-20120103-C00476.png)
NL (1) NL7509556A (US08088918-20120103-C00476.png)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4081537A (en) * 1975-10-10 1978-03-28 Schering Aktiengesellschaft Δ15 -Steroids and pharmaceutical compositions thereof
CH626095A5 (US08088918-20120103-C00476.png) * 1976-04-06 1981-10-30 Ciba Geigy Ag
ES469510A1 (es) * 1977-05-16 1978-12-01 Schering Ag Procedimiento para la preparacion de 17beta hidroxi-4-an- drosten-3-onas.
US4297350A (en) * 1978-10-10 1981-10-27 The Upjohn Company Male contraceptive steroids and methods of use
DE3710728A1 (de) * 1987-03-31 1988-10-13 Schering Ag Verfahren zur herstellung von 17(alpha)-ethinyl-17ss-hydroxy-18-methyl-4,15-estradien-3-on und die neuen zwischenprodukte fuer dieses verfahren
EP2268655A4 (en) * 2008-03-24 2013-03-13 Signa Chemistry Llc BIRCH REDUCTION OF STEROIDSUBSTRATES ON ALKALIMETAL SILICA GEL MATERIALS
CA2924255C (en) * 2013-09-18 2022-11-22 Crystal Pharma, S.A.U. Process for the preparation of estetrol

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3079408A (en) * 1963-02-26 Ig-bisoxygenated iy-haloestra-
US3501509A (en) * 1966-02-24 1970-03-17 Merck & Co Inc 13-alkylgona-1,3,5(10)-triene-17-one intermediates and process
US3433785A (en) * 1966-07-11 1969-03-18 Sterling Drug Inc 15,16-disubstituted aromatic steroids,intermediates and processes

Also Published As

Publication number Publication date
NL7509556A (nl) 1976-02-16
DK135997B (da) 1977-07-25
DK308175A (da) 1976-02-13
GB1515864A (en) 1978-06-28
BE832364A (fr) 1976-02-12
DE2439082A1 (de) 1976-02-26
DK135997C (da) 1978-01-23
US4016269A (en) 1977-04-05
JPS5148646A (en) 1976-04-26
CH624684A5 (US08088918-20120103-C00476.png) 1981-08-14
FR2281766B1 (US08088918-20120103-C00476.png) 1980-04-11

Similar Documents

Publication Publication Date Title
FR2279406A1 (fr) Nouveaux derives de quinazoline et medicament les contenant
FR2295739A1 (fr) Oxo-20 homopregnanes et medicaments qui en contiennent
FR2281123A1 (fr) Oxo-20 pregnanes et medicaments qui en contiennent
BE746656A (fr) 5-pyridyl-2-imidazolones et medicaments contenant ces composes
FR2289204A1 (fr) Nouveaux peptides et medicament contenant ces substances
FR2273554A1 (fr) Derives de prostaglandines et medicaments contenant ces substances
BE788321A (fr) Isoquinoleine-thiones et medicaments hypolipemiants en contenant
FR2312253A1 (fr) Derives de la piperazine et medicament contenant ces substances
FR2289192A1 (fr) Pyrazolo(1,5-a)pyridines et medicament contenant ces substances
FR2342973A1 (fr) Azapurines et medicaments contenant ces substances
FR2281766A1 (fr) Oestratetraenes et medicament contenant ces substances
BE785378A (fr) Benzoyl-urees, leur preparation et medicament contenant ces substances
FR2287908A1 (fr) Hydroxy-7 oestradiols et medicaments qui en contiennent
FR2331349A1 (fr) Benzodiazepines, leur preparation et medicament contenant ces substances
BE797623A (fr) Anilino-benzothiazoles leur preparation et medicament contenant ces subtances
BE836225R (fr) Acides 3-(4-biphenyl)alcanoiques et medicaments contenant ces composes
FR2342971A1 (fr) Derives de la purine et medicament contenant ces substances
FR2279418A1 (fr) Polypeptides utilisables comme contraceptifs et medicament contenant ces substances
FR2335228A1 (fr) Derives de la 5-fluoro-pyrimidine-4-one et medicament contenant ces substances
FR2280374A1 (fr) Derives de la phenylbutazone et medicament contenant ces substances
FR2315923A1 (fr) Derives de l'isoxazole et medicament contenant ces substances
FR2343477A1 (fr) Nouvelles phenylpyridylhydantoines substituees et medicament les contenant
FR2291758A1 (fr) Nouvelles benzodiazepines, leur preparation et medicament les contenant
BE778421A (fr) Benzene-sulfonyl-urees et medicament contenant ces substances
BE857535A (fr) Nouvelles organoprostaglandines et medicament les contenant

Legal Events

Date Code Title Description
ST Notification of lapse